SLC7A11 (also known as xCT), significantly upregulated in various human malignancies and crucial for tumor initiation, development, and drug resistance (27, 28), exhibits a dual regulatory role by governing both ferroptosis and disulfidptosis. The gene discussed is SLC7A11; the disease is neoplasm.